Alessandra Parisi

TL;DR: In vivo recombinant human erythropoietin effects on brain ischemic injury could be due to inhibition of NO overproduction, as indicated by reduction in nitrite and nitrate in the hippocampus, as observed after ischemia.

TL;DR: It is suggested that erythropoietin may be an effective therapeutic approach in improving healing in ischemic skin wounds by showing a higher level of vascular endothelial growth factor protein and an increased microvessel density in isChemic wounds with rHuEPO treatment than the normal incisional wounds and ischeMIC control wounds.

TL;DR: Treatment with recombinant human erythropoietin significantly reduced delayed neuronal death in the CA1 area of the hippocampus and prevented cognition impairment in the passive avoidance test, indicating that neuroprotective effects in brain ischemia are associated with the preservation of learning function.

TL;DR: The results indicate that the neurotransmitters studied could be involved in the anti-immobility effects of hypericum, and suggest that its antidepressant action is probably mediated by serotonergic, noradrenergic and dopaminergic system activation.

TL;DR: Increase of nitrite and nitrate was observed after cerebral ischemia in the hippocampus and it was dose-dependently reduced in animals pretreated with Ph-Gb, thus suggesting that neuroprotective effects of Ginkgo biloba may be due to an inhibitory action on nitric oxide formation.